Ondine Biomedical Inc. OBIMF

OBIMF Company Overview

Ondine Biomedical Inc. is a Canadian life sciences and medical technology company focused on light-activated antimicrobial therapies intended to prevent and treat infections. The company operates in the healthcare and biotechnology sectors, with a primary emphasis on photodisinfection-based technologies that use non-antibiotic antimicrobial approaches. Its lead commercial product platform, Steriwave, is designed to reduce pathogens in the nasal cavity before surgical procedures in order to lower the risk of surgical site infections. The company’s business model is centered on product commercialization, hospital adoption, clinical partnerships, and expansion of its antimicrobial technology platform into additional medical applications.

Ondine Biomedical was founded in Vancouver, British Columbia, and evolved from research into photodynamic therapy and antimicrobial resistance. Over time, the company shifted toward hospital infection prevention and healthcare-associated infection control, positioning itself within the broader movement toward non-antibiotic therapies amid growing concerns about antimicrobial resistance. Public disclosures and investor materials indicate that the company has pursued both commercial deployment and clinical validation strategies to support adoption in healthcare systems.